TechTalk: Taming the cytokine storm with near-patient immunoassay technology
Friday, August 14 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
A cytokine storm, or systemic hyperinflammation, is a life-threatening overreaction of the immune system that can rapidly drive organ failure, prolonged intensive care unit (ICU) stays and increased mortality. In critical care settings, early identification and intervention are essential, yet detecting and managing these complex inflammatory responses remains a significant clinical challenge.
Join this expert-led SelectScience® TechTalk to explore the challenges associated with cytokine storm detection and management in critical care settings. Learn about the latest approaches to anti-inflammatory interventions, strategies for identifying patients most likely to benefit from treatment, and the growing need for rapid diagnostic insights to support timely clinical decision-making in the ICU.
At the centre of this discussion is the Randox Evidence MultiSTAT™ immunoassay platform, a near-patient testing solution designed to deliver rapid inflammatory biomarker results when they matter most. Discover how MultiSTAT is helping to address gaps in current patient management by providing actionable data closer to the patient, with the potential to support patient stratification, streamline care pathways, and improve the balance between clinical outcomes and healthcare costs.
Presented by Dr. Scott McKeown, a Near Patient Diagnostics Manager with a published research background in chronic inflammation, respiratory disease and cancer, this session combines real-world clinical insight with expertise in the technologies shaping the future of critical care diagnostics.
Certificate of attendance
If you attend the live TechTalk, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes. If you view the on-demand TechTalk, you can request a certificate of attendance by emailing editor@selectscience.net.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available
Speakers
Who should attend?
- ICU consultants
- Emergency medicine consultants
- Medical directors
- Infectious disease specialists
- Clinical immunologists
- Point-of-care specialists
- Molecular diagnostics specialists
- Chief clinical officers
Featured products
Request Quote for All Products
Evidence MultiSTAT™ Multiplex Immunoassay Analyzer
Randox Laboratories Ltd.A compact, fully automated multiplex immunoassay analyzer using Biochip Array Technology for rapid detection of multiple analytes from a single sample. Supports high-throughput drug testing and clinical diagnostics with a simple cartridge-based workflow and results in under 30 minutes.
What will this webinar cover?
- The patient impact, management challenges and healthcare costs of a cytokine storm
- The current testing approaches and limitations for the field of critical care
- The need for better patient management tools in the ICU
- Randox's solution for the management of systemic hyperinflammation and its potential impact on patient care
Join the webinar to get answers to these questions:
- What is a cytokine storm and how does it impact ICU patients and healthcare costs?
- What are the current approaches to cytokine storm testing and their key limitations?
- Why are better tools needed for managing systemic hyperinflammation in critical care?
- How does the Randox Evidence MultiSTAT platform support rapid, near-patient inflammatory testing?
- In what ways can the Evidence MultiSTAT improve patient stratification, care pathways and clinical outcomes?